Nan Wu

3.6k citations
90 papers · 2.6k indexed · h-index 30
Topics
Cancer-related molecular mechanisms research (17 papers)RNA modifications and cancer (15 papers)MicroRNA in disease regulation (13 papers)
Journals
Journal of Biological ChemistryNature CommunicationsSHILAP Revista de lepidopterología
Partner nations
ChinaCanadaUnited States

In The Last Decade

Nan Wu

85 papers receiving 2.6k citations

Peers

Nan Wu
Comparison fields: 5 of 111
  • Molecular Biology 1.5k
  • Cancer Research 915
  • Pulmonary and Respiratory Medicine 352
  • Oncology 265
  • Epidemiology 265
Replace Ling Xu with:
Ling Xu China
Erica Novo Italy
Zhen‐Guo Ma China
Liankun Sun China
Hoi Young Lee South Korea
Li‐Der Hsiao Taiwan
Min Young Lee South Korea
Mojgan Djavaheri‐Mergny France
Nan Wu relative to Ling Xu China Ling Xu's profile →
Citations per field
00.5×1.5×1.9×
Ling Xu · 1×
Citations per year

Countries citing papers authored by Nan Wu

Since Specialization
Citations

This map shows the geographic impact of Nan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Wu more than expected).

Fields of papers citing papers by Nan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Wu. The network helps show where Nan Wu may publish in the future.

Co-authorship network of co-authors of Nan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Wu. A scholar is included among the top collaborators of Nan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Wu. Nan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 2
3 4
4 2
5 12
6 12
7 54
8 17
9 15
10 49
11 125
12 31
13 53
14 24
15 28
16 53
17 34
18
Outcomes of balloon eustachian tuboplasty for refractory otitis media with effusion
1
19 89
20 53

About Nan Wu

Nan Wu is a scholar working on Cancer Research, Otorhinolaryngology and Molecular Biology, having authored 90 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (17 papers), RNA modifications and cancer (15 papers) and MicroRNA in disease regulation (13 papers). The work is most often cited by research in Cancer Research (915 citations), Biochemistry (170 citations) and Molecular Biology (1.5k citations). Nan Wu has collaborated with scholars based in China, Canada and United States. Frequent co-authors include O Karmin, Yaw L. Siow, Christopher C.W. Hughes, Lindsei K. Sarna, Sun‐Young Hwang, Mingzuo Jiang, Katrina M. Welch-Reardon, Yi Chu, Yongzhan Nie and Haiming Liu. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026